HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
1.890
-0.010 (-0.53%)
At close: May 12, 2025, 4:00 PM
1.890
0.00 (0.00%)
After-hours: May 12, 2025, 4:03 PM EDT
HilleVax Market Cap
HilleVax has a market cap or net worth of $93.75 million as of May 12, 2025. Its market cap has decreased by -84.52% in one year.
Market Cap
93.75M
Enterprise Value
-41.25M
1-Year Change
-84.52%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since the IPO on April 29, 2022, HilleVax's market cap has decreased from $538.26M to $93.75M, a decrease of -82.58%. That is a compound annual growth rate of -43.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 94.25M | -5.60% |
| Dec 31, 2024 | 99.85M | -86.63% |
| Dec 29, 2023 | 746.58M | 25.20% |
| Dec 30, 2022 | 596.32M | 10.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |